Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/106258
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Puri, R. | - |
dc.contributor.author | Nissen, S. | - |
dc.contributor.author | Shao, M. | - |
dc.contributor.author | Elshazly, M. | - |
dc.contributor.author | Kataoka, Y. | - |
dc.contributor.author | Kapadia, S. | - |
dc.contributor.author | Tuzcu, E. | - |
dc.contributor.author | Nicholls, S. | - |
dc.date.issued | 2016 | - |
dc.identifier.citation | Arteriosclerosis, Thrombosis and Vascular Biology, 2016; 36(11):2220-2228 | - |
dc.identifier.issn | 1079-5642 | - |
dc.identifier.issn | 1524-4636 | - |
dc.identifier.uri | http://hdl.handle.net/2440/106258 | - |
dc.description.abstract | Objectives: Non–high-density lipoprotein cholesterol (non-HDLC) levels reflect the full burden of cholesterol transported in atherogenic lipoproteins. Genetic studies suggest a causal association between elevated triglycerides (TGs)-rich lipoproteins and atherosclerosis. We evaluated associations between achieved non-HDLC and TG levels on changes in coronary atheroma volume. Approach and Results: Data were analyzed from 9 clinical trials involving 4957 patients with coronary disease undergoing serial intravascular ultrasonography to assess changes in percent atheroma volume (ΔPAV) and were evaluated against on-treatment non-HDLC and TG levels. The effects of lower (<100 mg/dL) versus higher (≥100 mg/dL) achieved non-HDLC levels and lower (<200 mg/dL) versus higher (≥200 mg/dL) achieved TG levels were evaluated in populations with variable on-treatment low-density lipoprotein cholesterol (LDLC) </≥70 mg/dL and C-reactive protein </≥2 mg/L and in patients with or without diabetes mellitus. On-treatment non-HDLC levels linearly associated with ΔPAV. Overt PAV progression (ΔPAV>0) was associated with achieved TG levels >200 mg/dL, respectively. Lower on-treatment non-HDLC and TG levels associated with significant PAV regression compared with higher non-HDLC and TG levels across all levels of LDLC and C-reactive protein and irrespective of diabetic status (P<0.001 across all comparisons). ΔPAV were more strongly influenced by changes in non-HDLC (β=0.62; P<0.001) compared with changes in LDLC (β=0.51; P<0.001). Kaplan–Meier sensitivity analyses demonstrated significantly greater major adverse cardiovascular event rates in those with higher versus lower non-HDLC and TG levels, with an earlier separation of the non-HDLC compared with the LDLC curve. Conclusions: Achieved non-HDLC levels seem more closely associated with coronary atheroma progression than LDLC. Plaque progression associates with achieved TGs, but only above levels of 200 mg/dL. These observations support a more prominent role for non-HDLC (and possibly TG) lowering in combating residual cardiovascular risk. | - |
dc.description.statementofresponsibility | Rishi Puri, Steven E. Nissen, Mingyuan Shao, Mohamed B. Elshazly, Yu Kataoka, Samir R. Kapadia, E. Murat Tuzcu, Stephen J. Nicholls | - |
dc.language.iso | en | - |
dc.publisher | Lippincott Williams & Wilkins | - |
dc.rights | © 2016 American Heart Association, Inc. | - |
dc.source.uri | http://dx.doi.org/10.1161/atvbaha.116.307601 | - |
dc.subject | Atherosclerosis; low-density lipoprotein; non-HDL; residual risk; triglycerides | - |
dc.title | Non-HDL cholesterol and triglycerides: implications for coronary atheroma progression and clinical events | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1161/ATVBAHA.116.307601 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Puri, R. [0000-0001-8849-7426] | - |
dc.identifier.orcid | Nicholls, S. [0000-0002-9668-4368] | - |
Appears in Collections: | Aurora harvest 8 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.